Algert Global’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.18M | Buy |
1,070,139
+111,647
| +12% | +$644K | 0.13% | 262 |
|
|
2025
Q1 | $6.33M | Buy |
958,492
+74,789
| +8% | +$494K | 0.16% | 200 |
|
|
2024
Q4 | $7.7M | Buy |
883,703
+611,427
| +225% | +$5.33M | 0.18% | 171 |
|
|
2024
Q3 | $5.32M | Buy |
272,276
+11,493
| +4% | +$225K | 0.14% | 233 |
|
|
2024
Q2 | $5.37M | Sell |
260,783
-18,787
| -7% | -$387K | 0.18% | 158 |
|
|
2024
Q1 | $5.96M | Sell |
279,570
-53,880
| -16% | -$1.15M | 0.23% | 118 |
|
|
2023
Q4 | $4.8M | Sell |
333,450
-31,574
| -9% | -$454K | 0.19% | 147 |
|
|
2023
Q3 | $3.33M | Buy |
365,024
+177,959
| +95% | +$1.62M | 0.16% | 207 |
|
|
2023
Q2 | $1.98M | Buy |
187,065
+54,510
| +41% | +$577K | 0.09% | 390 |
|
|
2023
Q1 | $1.62M | Sell |
132,555
-29,361
| -18% | -$359K | 0.08% | 421 |
|
|
2022
Q4 | $2.01M | Sell |
161,916
-21,200
| -12% | -$263K | 0.11% | 296 |
|
|
2022
Q3 | $2.5M | Buy |
183,116
+70,999
| +63% | +$970K | 0.15% | 206 |
|
|
2022
Q2 | $2.06M | Buy |
112,117
+20,680
| +23% | +$379K | 0.15% | 180 |
|
|
2022
Q1 | $1.47M | Buy |
91,437
+54,132
| +145% | +$870K | 0.1% | 355 |
|
|
2021
Q4 | $522K | Sell |
37,305
-7,280
| -16% | -$102K | 0.07% | 521 |
|
|
2021
Q3 | $835K | Buy |
44,585
+11,983
| +37% | +$224K | 0.11% | 321 |
|
|
2021
Q2 | $680K | Sell |
32,602
-6,996
| -18% | -$146K | 0.23% | 143 |
|
|
2021
Q1 | $1.12M | Sell |
39,598
-37,150
| -48% | -$1.05M | 0.36% | 96 |
|
|
2020
Q4 | $2.51M | Buy |
76,748
+28,059
| +58% | +$917K | 0.71% | 22 |
|
|
2020
Q3 | $1.49M | Sell |
48,689
-24,857
| -34% | -$762K | 0.47% | 66 |
|
|
2020
Q2 | $1.2M | Sell |
73,546
-8,171
| -10% | -$133K | 0.41% | 78 |
|
|
2020
Q1 | $813K | Buy |
81,717
+52,800
| +183% | +$525K | 0.34% | 111 |
|
|
2019
Q4 | $398K | Buy |
+28,917
| New | +$398K | 0.12% | 230 |
|